Exposure to Inorganic Arsenic in Drinking Water Increases Cardiovascular Risk

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 23, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 23, 2024 -- Long-term exposure to inorganic arsenic in drinking water (wAs) from U.S. community water supplies (CWS) at levels below the federal maximum contaminant level of 10 µg/L is associated with an increased risk for cardiovascular disease, including ischemic heart disease, according to a study published online Oct. 23 in Environmental Health Perspectives.

Danielle N. Medgyesi, from the Mailman School of Public Health at Columbia University in New York City, and colleagues examined the relationship between long-term wAs exposure from CWS and cardiovascular disease using statewide health care administrative records from women in the California Teachers Study. Participants' residential addresses were linked to CWS boundaries and annual wAs concentrations for 1990 to 2020. Exposure was calculated as a 10-year moving average up to participant event, death, or end of follow-up.

The analysis included 98,250 participants, with 6,119 ischemic heart disease cases and 9,936 cardiovascular disease cases. The researchers found that for ischemic heart disease, the hazard ratios (95 percent confidence intervals) at concentration thresholds were 1.06 (1.00 to 1.12), 1.05 (0.94 to 1.17), 1.20 (1.02 to 1.41), and 1.42 (1.10 to 1.84) for 1.00 to 2.99, 3.00 to 4.99, 5.00 to 9.99, and ≥10 µg/L, respectively, compared with <1 µg/L. For every doubling of wAs exposure, the hazard ratios (95 percent confidence intervals) were 1.04 (1.02 to 1.06) and 1.02 (1.01 to 1.04) for ischemic heart disease and cardiovascular disease, respectively. The risk was stronger for those aged 55 years and younger versus those older than 55 years at enrollment.

"This study is one of the first to comprehensively describe risks at exposure levels below the current regulatory limit," the authors write. "Our results are novel and encourage a renewed discussion of current policy and regulatory standards."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-24 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords